252 related articles for article (PubMed ID: 10764695)
1. Is there still a need for albumin infusions to treat patients with liver disease?
Ginès P; Arroyo V
Gut; 2000 May; 46(5):588-90. PubMed ID: 10764695
[No Abstract] [Full Text] [Related]
2. [Physiopathology of refractory ascites and the hepatorenal syndrome].
Arroyo V
Nefrologia; 2002; 22 Suppl 5():41-6. PubMed ID: 12107916
[No Abstract] [Full Text] [Related]
3. Ascites and hepatorenal syndrome in cirrhosis: pathophysiological basis of therapy and current management.
Arroyo V; Colmenero J
J Hepatol; 2003; 38 Suppl 1():S69-89. PubMed ID: 12591187
[No Abstract] [Full Text] [Related]
4. [Vasoconstrictors in the treatment of hepatorenal syndrome].
Ortega R; Calahorra B; Ginès P
Nefrologia; 2002; 22 Suppl 5():56-61. PubMed ID: 12107919
[No Abstract] [Full Text] [Related]
5. [Hepatorenal syndrome: diagnosis, treatment and prevention].
Egerod Israelsen M; Gluud LL; Bendtsen F; Møller S; Krag AA
Ugeskr Laeger; 2013 May; 175(22):1562-6. PubMed ID: 23721840
[TBL] [Abstract][Full Text] [Related]
6. Midodrine, octreotide, albumin, and TIPS in selected patients with cirrhosis and type 1 hepatorenal syndrome.
Wong F; Pantea L; Sniderman K
Hepatology; 2004 Jul; 40(1):55-64. PubMed ID: 15239086
[TBL] [Abstract][Full Text] [Related]
7. Hepatorenal syndrome: Current concepts related to diagnosis and management.
de Mattos ÁZ; de Mattos AA; Méndez-Sánchez N
Ann Hepatol; 2016; 15(4):474-81. PubMed ID: 27236146
[TBL] [Abstract][Full Text] [Related]
8. Reversibility of hepatorenal syndrome by prolonged administration of ornipressin and plasma volume expansion.
Guevara M; Ginès P; Fernández-Esparrach G; Sort P; Salmerón JM; Jiménez W; Arroyo V; Rodés J
Hepatology; 1998 Jan; 27(1):35-41. PubMed ID: 9425914
[TBL] [Abstract][Full Text] [Related]
9. Towards goal-directed therapy of hepatorenal syndrome: we have the tools but we need the trials.
Mookerjee RP; Jalan R
Crit Care; 2008; 12(2):119. PubMed ID: 18394181
[TBL] [Abstract][Full Text] [Related]
10. [Influence of circulatory dysfunction on the treatment of ascites and hepatorenal syndrome: vasoconstrictor and diuretic drug treatment].
Torre A; Terra C; Guevara M; Ginès P
Gastroenterol Hepatol; 2004 Feb; 27 Suppl 1():8-14. PubMed ID: 15195529
[No Abstract] [Full Text] [Related]
11. Management of ascites and hepatorenal syndrome.
Piano S; Tonon M; Angeli P
Hepatol Int; 2018 Feb; 12(Suppl 1):122-134. PubMed ID: 28836115
[TBL] [Abstract][Full Text] [Related]
12. [Hepatorenal syndrome].
Bosma JW; van Meyel JJ; Siegert CE
Ned Tijdschr Geneeskd; 2010; 154():A1355. PubMed ID: 20456764
[No Abstract] [Full Text] [Related]
13. Management of cirrhosis and ascites.
Ginès P; Cárdenas A; Arroyo V; Rodés J
N Engl J Med; 2004 Apr; 350(16):1646-54. PubMed ID: 15084697
[No Abstract] [Full Text] [Related]
14. Ascites and renal functional abnormalities in cirrhosis. Pathogenesis and treatment.
Ginès P; Fernández-Esparrach G; Arroyo V
Baillieres Clin Gastroenterol; 1997 Jun; 11(2):365-85. PubMed ID: 9395753
[TBL] [Abstract][Full Text] [Related]
15. Terlipressin versus albumin in paracentesis-induced circulatory dysfunction in cirrhosis: a randomized study.
Singh V; Kumar R; Nain CK; Singh B; Sharma AK
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 2):303-7. PubMed ID: 16460491
[TBL] [Abstract][Full Text] [Related]
16. [Treatment of hepatorenal syndrome].
Guevara M
Gastroenterol Hepatol; 2003 Apr; 26(4):270-4. PubMed ID: 12681123
[No Abstract] [Full Text] [Related]
17. Effects of plasma expansion with albumin and paracentesis on haemodynamics and kidney function in critically ill cirrhotic patients with tense ascites and hepatorenal syndrome: a prospective uncontrolled trial.
Umgelter A; Reindl W; Wagner KS; Franzen M; Stock K; Schmid RM; Huber W
Crit Care; 2008; 12(1):R4. PubMed ID: 18197961
[TBL] [Abstract][Full Text] [Related]
18. Renal and neurohormonal changes following simultaneous administration of systemic vasoconstrictors and dopamine or prostacyclin in cirrhotic patients with hepatorenal syndrome.
Saló J; Ginès A; Quer JC; Fernández-Esparrach G; Guevara M; Ginès P; Bataller R; Planas R; Jiménez W; Arroyo V; Rodés J
J Hepatol; 1996 Dec; 25(6):916-23. PubMed ID: 9007721
[TBL] [Abstract][Full Text] [Related]
19. The management of hepatorenal syndrome.
Carl DE; Sanyal A
Minerva Gastroenterol Dietol; 2009 Jun; 55(2):207-26. PubMed ID: 19305378
[TBL] [Abstract][Full Text] [Related]
20. Ascites and hepatorenal syndrome: pathogenesis and treatment strategies.
Ginès P; Arroyo V; Rodés J
Adv Intern Med; 1998; 43():99-142. PubMed ID: 9506180
[No Abstract] [Full Text] [Related]
[Next] [New Search]